Zecotek Receives Initial Purchase Orders Having Set Pricing and Performance Specifications for its High-Performance RFO Vanadate Crystals
Vancouver, BC, September 11, 2008 – Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) today announced that Zecotek Laser Systems Singapore Pte. Ltd., a wholly-owned subsidiary, has received purchase orders for its proprietary high-performance Rare-Earth Fine Oxide (RFO) Vanadate Crystals for laser applications. The announcement follows the initial sales and qualification of its neodymium doped yttrium vanadate laser cavity crystals by major U.S and European based laser manufacturers. Zecotek has been working closely with industry leading laser manufactures to align quality testing procedures and standards and reached mutual agreement on final specifications and pricing levels. The vanadate crystals are expected to be used in a new series of high-performance industrial lasers. For competitive reasons terms of the purchase orders remain confidential.
“We have worked very closely with leading laser companies to finalize the performance and quality specifications necessary to compete on the global stage,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. “Our proprietary high-performance RFO Vanadates are being well received by the OEM laser community because our crystals have the competitive advantage of significantly improved performance, cost and adaptability to a widerrange of laser applications. Furthermore, by using proprietary crystal manufacturing techniques we are able to fabricate the largest laser cavity elements with the lowest bulk absorption.”
Zecotek recently initiated commercial production of the Company’s proprietary, high-performance RFO Vanadate Crystals at its laboratory facilities in Singapore. The proprietary growth technology has been under development for three years and the resulting RFO Vanadate Crystal competes directly with the ubiquitous YAG crystal, which is presently used in 60% of all laser applications. Zecotek’s RFO Vanadate offers manufactures significant performance improvement and adaptability to a wide range of research, manufacturing and medical applications.
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), is a photonics technology company developing high-performance crystals, photo detectors, lasers, optical imaging and 3D display technologies for commercial applications in the medical diagnostics and high-tech industries. Founded in 2003, the company operates three distinct divisions: imaging, lasers and 3D display, with labs located in Canada, USA, Singapore and Russia. Zecotek commercializes its novel, patented and patent-pending photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders. For more information, please visit Zecotek Photonics.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For product and technical information please contact:
Zecotek Photonics Inc.
SUSANA MENDEZ ALCALA
T: (604) 827-5232
For investor information please contact:
Caliber Capital Partners
T: (778) 327-6678
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.